Neo Modulus Secures Series B Funding for Regenerative Medical Device Development
Neo Modulus, a developer of regenerative implantable medical devices based in Suzhou, has reportedly raised...
Finance
Siyi Intelligence Raises Series A Funding for Neural Rehabilitation Solutions
Siyi Intelligence, a developer of soft rehabilitation robots based in Shanghai, has reportedly raised close...
PulseCare Raises Pre-Series A Funding for Minimally Invasive Treatment Devices
PulseCare, a Shenzhen-based maker of minimally and non-invasive treatment devices, has reportedly raised “tens of...
TinKer Bio Raises Series A+ Funding for Microfluidic Chip Expansion
China-based Hangzhou TinKer BioTechnology Co., Ltd, a leading microfluidic chip technology platform company, has reportedly...
Hexin Medical Technology Raises Series A Funding for Radionuclide Therapy
Hexin Medical Technology Co., Ltd, a radionuclide therapy developer based in Suzhou, has reportedly raised...
TandemAI Secures $35M Series A to Expand Drug Discovery Platform
TandemAI, a technology firm with operations in New York, San Diego, and China, has successfully...
Merck Reports 12.9% Sales Growth in 2022 Annual Report
German major Merck (NYSE: MRK) released its 2022 annual report this week, showing a robust...
Pengyang Yiliao Raises Series B+ Funds for Cardiovascular Product Development
Pengyang Yiliao, a Beijing-based developer and manufacturer of cardiovascular technology, has reportedly raised “tens of...
Glowe Raises Series A+ Funding to Expand AIGC in Mental Health
Glowe, an online psychological consultation platform based in Guangdong, has reportedly raised “tens of millions”...
Geneus Tech Secures Funding for Gseq500 Gene Sequencer Production
Geneus Tech, a Shenzhen-based developer and manufacturer of gene sequencers, has reportedly raised an undisclosed...
Bayer Reports 2022 Sales Growth, Highlights New Drug Performances
Germany-based Bayer (ETR: BAYN) released its 2022 annual report this week, revealing a global sales...
China’s NRDL Update and Expansion of ‘Dual Channel’ Drug Access
The latest update to China’s National Reimbursement Drug List (NRDL) was implemented from March 1,...
Eluminex Biosciences Closes $40M Series B for Ophthalmic Innovations
China-based ophthalmic biotech Eluminex Biosciences (Suzhou) Ltd has announced the closure of a Series B...
RinuaGene Raises $14.4M in Pre-Series A+ for mRNA Drug Development
RinuaGene, an mRNA-based drug developer based in Suzhou, has reportedly raised close to RMB 100...
Oricell Therapeutics Closes $45M Series B1 Round for Cellular Immunotherapy
China-based tumor cellular immunotherapeutics developer Oricell Therapeutics Co., Ltd has announced the closing of a...
Immorna Closes Series A+ and A++ Rounds Near $100M for mRNA Development
Immorna (Hangzhou) Biotechnology Co., Ltd has announced the successful closure of Series A+ and A++...
Danatlas Raises Pre-Series A Funding for Synthetic Lethality Drug Development
Beijing-headquartered Danatlas, a first-in-class drug developer specializing in the synthetic lethality field, has reportedly raised...
ConjuStar Peptide-Drug Conjugate Angel Financing
Tianjin-based ConjuStar, a peptide-drug conjugate (PDC) developer incubated by Fosun Pharma and Wuxi Apptec, has...
Lepu and Keymed License CLDN18.2 ADC CMG901 to AstraZeneca
China-based firms Lepu Biopharma Co., Ltd (HKG: 2157) and Keymed Biosciences Inc. (HKG: 2162) have...
TransThera Biosciences Completes Series D+ Financing Round
China’s Nanjing TransThera Sciences (Nanjing), Inc. has announced the completion of a Series D+ financing...